Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 5456s-5461s, October 1, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weisenburger, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weisenburger, D. D.

Pathological Classification of Non-Hodgkin's Lymphoma for Epidemiological Studies1

Dennis D. Weisenburger2

Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska 68198-3135

Non-Hodgkin's lymphoma (NHL) consists of a heterogeneous group of disorders which have been difficult to study by epidemiological means in the past. However, recent advances in knowledge of the biology of NHL and improvements in its classification will greatly improve the quality of epidemiological studies in the future. Use of the Working Formulation and the current International Classification of Diseases for Oncology, along with paraffin immunohistochemistry, allow the delineation of NHL subgroups with possible etiological significance based on the biology of the disease. The collaboration of epidemiologists with expert pathologists in the design, performance, and evaluation of epidemiological studies of NHL is essential for such studies to be meaningful.




This article has been cited by other articles:


Home page
J Natl Cancer Inst MonogrHome page
B. C.-H. Chiu, Q. Lan, B. J. Dave, A. Blair, S. H. Zahm, and D. D. Weisenburger
The Utility of t(14;18) in Understanding Risk Factors for Non-Hodgkin Lymphoma
J Natl Cancer Inst Monographs, July 1, 2008; 2008(39): 69 - 73.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.